Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hogan

Showing results (1151-1160 of 1,303) with videos related to

Pageof 131
Sort By:
Neurology|March 26, 2017
Cardiorespiratory fitness alters the influence of a polygenic risk score on biomarkers of ADStephanie A Schultz, Elizabeth A Boots, Burcu F Darst, et al.
American Journal of Hematology|February 18, 2026
TP53 Mutations and Circulating Blasts ≥ 20% Are the Primary Determinants of Survival in Accelerated/Blast-Phase Myeloproliferative Neoplasms Treated With Frontline Venetoclax Plus Hypomethylating AgentNaseema Gangat, Momna Warraich, Sudhesh Kumar, et al.
American Journal of Hematology|June 15, 2022
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapyAyalew Tefferi, Naseema Gangat, Aref Al-Kali, et al.
Physical Review Letters|August 11, 2005
Multi-GeV energy gain in a plasma-wakefield acceleratorM J Hogan, C D Barnes, C E Clayton, et al.
Transfusion|July 13, 2020
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902Francine M Foss, Xin Victoria Wang, Selina M Luger, et al.
Peerj|March 1, 2017
Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessmentValentina S Vysotskaia, Gregory J Hogan, Genevieve M Gould, et al.
Immunity|December 9, 2020
SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody GenerationKatlyn Lederer, Diana Castaño, Daniela Gómez Atria, et al.
Neurology|May 5, 2017
<i>BDNF</i> Val66Met predicts cognitive decline in the Wisconsin Registry for Alzheimer's PreventionElizabeth A Boots, Stephanie A Schultz, Lindsay R Clark, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 18, 2014
A phase 1/2a follistatin gene therapy trial for becker muscular dystrophyJerry R Mendell, Zarife Sahenk, Vinod Malik, et al.
Physical Review Letters|April 26, 2018
Measurement of Transverse Wakefields Induced by a Misaligned Positron Bunch in a Hollow Channel Plasma AcceleratorC A Lindstrøm, E Adli, J M Allen, et al.
Pageof 131

Showing results (1151-1160 of 1,303) with videos related to

Sort By:
Pageof 131
Neurology|March 26, 2017
Cardiorespiratory fitness alters the influence of a polygenic risk score on biomarkers of ADStephanie A Schultz, Elizabeth A Boots, Burcu F Darst, et al.
American Journal of Hematology|February 18, 2026
TP53 Mutations and Circulating Blasts ≥ 20% Are the Primary Determinants of Survival in Accelerated/Blast-Phase Myeloproliferative Neoplasms Treated With Frontline Venetoclax Plus Hypomethylating AgentNaseema Gangat, Momna Warraich, Sudhesh Kumar, et al.
American Journal of Hematology|June 15, 2022
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapyAyalew Tefferi, Naseema Gangat, Aref Al-Kali, et al.
Physical Review Letters|August 11, 2005
Multi-GeV energy gain in a plasma-wakefield acceleratorM J Hogan, C D Barnes, C E Clayton, et al.
Transfusion|July 13, 2020
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902Francine M Foss, Xin Victoria Wang, Selina M Luger, et al.
Peerj|March 1, 2017
Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessmentValentina S Vysotskaia, Gregory J Hogan, Genevieve M Gould, et al.
Immunity|December 9, 2020
SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody GenerationKatlyn Lederer, Diana Castaño, Daniela Gómez Atria, et al.
Neurology|May 5, 2017
<i>BDNF</i> Val66Met predicts cognitive decline in the Wisconsin Registry for Alzheimer's PreventionElizabeth A Boots, Stephanie A Schultz, Lindsay R Clark, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 18, 2014
A phase 1/2a follistatin gene therapy trial for becker muscular dystrophyJerry R Mendell, Zarife Sahenk, Vinod Malik, et al.
Physical Review Letters|April 26, 2018
Measurement of Transverse Wakefields Induced by a Misaligned Positron Bunch in a Hollow Channel Plasma AcceleratorC A Lindstrøm, E Adli, J M Allen, et al.
Pageof 131